The global Oral Asthma Medications market was valued at US$ 652 million in 2023 and is anticipated to reach US$ 969 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

Oral Asthma Medications Market

Oral asthma medications play a critical role in managing asthma, particularly for patients who require additional control beyond inhaled therapies or who have difficulty using inhalers. These medications include leukotriene modifiers (e.g., montelukast), which help reduce inflammation and bronchoconstriction by blocking leukotrienes, and oral corticosteroids (e.g., prednisone), used for short-term management of severe exacerbations due to their potent anti-inflammatory effects.

North American market for Oral Asthma Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Asthma Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Oral Asthma Medications include Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Asthma Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Asthma Medications.

The Oral Asthma Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral Asthma Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Asthma Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Asthma Medications Market Report

Report Metric	Details
Report Name	Oral Asthma Medications Market
Accounted market size in 2023	US$ 652 million
Forecasted market size in 2030	US$ 969 million
CAGR	5.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tablets Capsules
Segment by Application	Anti-inflammatory Bronchodilators Combination Therapy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Asthma Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Asthma Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Asthma Medications Market growing?

Ans: The Oral Asthma Medications Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the Oral Asthma Medications Market size in 2030?

Ans: The Oral Asthma Medications Market size in 2030 will be US$ 969 million.

Who are the main players in the Oral Asthma Medications Market report?

Ans: The main players in the Oral Asthma Medications Market are Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma

What are the Application segmentation covered in the Oral Asthma Medications Market report?

Ans: The Applications covered in the Oral Asthma Medications Market report are Anti-inflammatory, Bronchodilators, Combination Therapy, Other

What are the Type segmentation covered in the Oral Asthma Medications Market report?

Ans: The Types covered in the Oral Asthma Medications Market report are Tablets, Capsules

1 Oral Asthma Medications Market Overview

1.1 Product Definition

1.2 Oral Asthma Medications by Type

1.2.1 Global Oral Asthma Medications Market Value Comparison by Type (2024-2030)

1.2.2 Tablets

1.2.3 Capsules

1.3 Oral Asthma Medications by Application

1.3.1 Global Oral Asthma Medications Market Value by Application (2024-2030)

1.3.2 Anti-inflammatory

1.3.3 Bronchodilators

1.3.4 Combination Therapy

1.3.5 Other

1.4 Global Oral Asthma Medications Market Size Estimates and Forecasts

1.4.1 Global Oral Asthma Medications Revenue 2019-2030

1.4.2 Global Oral Asthma Medications Sales 2019-2030

1.4.3 Global Oral Asthma Medications Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Oral Asthma Medications Market Competition by Manufacturers

2.1 Global Oral Asthma Medications Sales Market Share by Manufacturers (2019-2024)

2.2 Global Oral Asthma Medications Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Oral Asthma Medications Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Oral Asthma Medications, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Asthma Medications, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Asthma Medications, Product Type & Application

2.7 Global Key Manufacturers of Oral Asthma Medications, Date of Enter into This Industry

2.8 Global Oral Asthma Medications Market Competitive Situation and Trends

2.8.1 Global Oral Asthma Medications Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oral Asthma Medications Players Market Share by Revenue

2.8.3 Global Oral Asthma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Asthma Medications Market Scenario by Region

3.1 Global Oral Asthma Medications Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Oral Asthma Medications Sales by Region: 2019-2030

3.2.1 Global Oral Asthma Medications Sales by Region: 2019-2024

3.2.2 Global Oral Asthma Medications Sales by Region: 2025-2030

3.3 Global Oral Asthma Medications Revenue by Region: 2019-2030

3.3.1 Global Oral Asthma Medications Revenue by Region: 2019-2024

3.3.2 Global Oral Asthma Medications Revenue by Region: 2025-2030

3.4 North America Oral Asthma Medications Market Facts & Figures by Country

3.4.1 North America Oral Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Oral Asthma Medications Sales by Country (2019-2030)

3.4.3 North America Oral Asthma Medications Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Asthma Medications Market Facts & Figures by Country

3.5.1 Europe Oral Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Oral Asthma Medications Sales by Country (2019-2030)

3.5.3 Europe Oral Asthma Medications Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Asthma Medications Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Asthma Medications Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Oral Asthma Medications Sales by Region (2019-2030)

3.6.3 Asia Pacific Oral Asthma Medications Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oral Asthma Medications Market Facts & Figures by Country

3.7.1 Latin America Oral Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Oral Asthma Medications Sales by Country (2019-2030)

3.7.3 Latin America Oral Asthma Medications Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Oral Asthma Medications Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Oral Asthma Medications Sales by Country (2019-2030)

3.8.3 Middle East and Africa Oral Asthma Medications Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Asthma Medications Sales by Type (2019-2030)

4.1.1 Global Oral Asthma Medications Sales by Type (2019-2024)

4.1.2 Global Oral Asthma Medications Sales by Type (2025-2030)

4.1.3 Global Oral Asthma Medications Sales Market Share by Type (2019-2030)

4.2 Global Oral Asthma Medications Revenue by Type (2019-2030)

4.2.1 Global Oral Asthma Medications Revenue by Type (2019-2024)

4.2.2 Global Oral Asthma Medications Revenue by Type (2025-2030)

4.2.3 Global Oral Asthma Medications Revenue Market Share by Type (2019-2030)

4.3 Global Oral Asthma Medications Price by Type (2019-2030)

5 Segment by Application

5.1 Global Oral Asthma Medications Sales by Application (2019-2030)

5.1.1 Global Oral Asthma Medications Sales by Application (2019-2024)

5.1.2 Global Oral Asthma Medications Sales by Application (2025-2030)

5.1.3 Global Oral Asthma Medications Sales Market Share by Application (2019-2030)

5.2 Global Oral Asthma Medications Revenue by Application (2019-2030)

5.2.1 Global Oral Asthma Medications Revenue by Application (2019-2024)

5.2.2 Global Oral Asthma Medications Revenue by Application (2025-2030)

5.2.3 Global Oral Asthma Medications Revenue Market Share by Application (2019-2030)

5.3 Global Oral Asthma Medications Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Company Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Pharmaceutical Oral Asthma Medications Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Oral Asthma Medications Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Merck Oral Asthma Medications Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Roche Oral Asthma Medications Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Oral Asthma Medications Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Boehringer Ingelheim International

6.6.1 Boehringer Ingelheim International Company Information

6.6.2 Boehringer Ingelheim International Description and Business Overview

6.6.3 Boehringer Ingelheim International Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boehringer Ingelheim International Oral Asthma Medications Product Portfolio

6.6.5 Boehringer Ingelheim International Recent Developments/Updates

6.7 Sanofi

6.7.1 Sanofi Company Information

6.7.2 Sanofi Description and Business Overview

6.7.3 Sanofi Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Sanofi Oral Asthma Medications Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 BD

6.8.1 BD Company Information

6.8.2 BD Description and Business Overview

6.8.3 BD Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.8.4 BD Oral Asthma Medications Product Portfolio

6.8.5 BD Recent Developments/Updates

6.9 Covis Pharma

6.9.1 Covis Pharma Company Information

6.9.2 Covis Pharma Description and Business Overview

6.9.3 Covis Pharma Oral Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Covis Pharma Oral Asthma Medications Product Portfolio

6.9.5 Covis Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Asthma Medications Industry Chain Analysis

7.2 Oral Asthma Medications Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Asthma Medications Production Mode & Process

7.4 Oral Asthma Medications Sales and Marketing

7.4.1 Oral Asthma Medications Sales Channels

7.4.2 Oral Asthma Medications Distributors

7.5 Oral Asthma Medications Customers

8 Oral Asthma Medications Market Dynamics

8.1 Oral Asthma Medications Industry Trends

8.2 Oral Asthma Medications Market Drivers

8.3 Oral Asthma Medications Market Challenges

8.4 Oral Asthma Medications Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International

Sanofi

Covis Pharma

List of Tables

Table 1. Global Oral Asthma Medications Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Oral Asthma Medications Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Oral Asthma Medications Market Competitive Situation by Manufacturers in 2023

Table 4. Global Oral Asthma Medications Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Oral Asthma Medications Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Oral Asthma Medications Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Oral Asthma Medications Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Oral Asthma Medications Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Oral Asthma Medications, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Asthma Medications, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Asthma Medications, Product Type & Application

Table 12. Global Key Manufacturers of Oral Asthma Medications, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Asthma Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Asthma Medications as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Asthma Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Oral Asthma Medications Sales by Region (2019-2024) & (K Units)

Table 18. Global Oral Asthma Medications Sales Market Share by Region (2019-2024)

Table 19. Global Oral Asthma Medications Sales by Region (2025-2030) & (K Units)

Table 20. Global Oral Asthma Medications Sales Market Share by Region (2025-2030)

Table 21. Global Oral Asthma Medications Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Oral Asthma Medications Revenue Market Share by Region (2019-2024)

Table 23. Global Oral Asthma Medications Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Oral Asthma Medications Revenue Market Share by Region (2025-2030)

Table 25. North America Oral Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Oral Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 27. North America Oral Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 28. North America Oral Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Oral Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Oral Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Oral Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 32. Europe Oral Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 33. Europe Oral Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Oral Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Oral Asthma Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Oral Asthma Medications Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Oral Asthma Medications Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Oral Asthma Medications Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Oral Asthma Medications Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Oral Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Oral Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Oral Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Oral Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oral Asthma Medications Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Oral Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Oral Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Oral Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Oral Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Oral Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Oral Asthma Medications Sales (K Units) by Type (2019-2024)

Table 51. Global Oral Asthma Medications Sales (K Units) by Type (2025-2030)

Table 52. Global Oral Asthma Medications Sales Market Share by Type (2019-2024)

Table 53. Global Oral Asthma Medications Sales Market Share by Type (2025-2030)

Table 54. Global Oral Asthma Medications Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Oral Asthma Medications Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Oral Asthma Medications Revenue Market Share by Type (2019-2024)

Table 57. Global Oral Asthma Medications Revenue Market Share by Type (2025-2030)

Table 58. Global Oral Asthma Medications Price (US$/Unit) by Type (2019-2024)

Table 59. Global Oral Asthma Medications Price (US$/Unit) by Type (2025-2030)

Table 60. Global Oral Asthma Medications Sales (K Units) by Application (2019-2024)

Table 61. Global Oral Asthma Medications Sales (K Units) by Application (2025-2030)

Table 62. Global Oral Asthma Medications Sales Market Share by Application (2019-2024)

Table 63. Global Oral Asthma Medications Sales Market Share by Application (2025-2030)

Table 64. Global Oral Asthma Medications Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Oral Asthma Medications Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Oral Asthma Medications Revenue Market Share by Application (2019-2024)

Table 67. Global Oral Asthma Medications Revenue Market Share by Application (2025-2030)

Table 68. Global Oral Asthma Medications Price (US$/Unit) by Application (2019-2024)

Table 69. Global Oral Asthma Medications Price (US$/Unit) by Application (2025-2030)

Table 70. Teva Pharmaceutical Company Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Teva Pharmaceutical Oral Asthma Medications Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GSK Oral Asthma Medications Product

Table 79. GSK Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Merck Oral Asthma Medications Product

Table 84. Merck Recent Developments/Updates

Table 85. Roche Company Information

Table 86. Roche Description and Business Overview

Table 87. Roche Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Roche Oral Asthma Medications Product

Table 89. Roche Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. AstraZeneca Oral Asthma Medications Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Boehringer Ingelheim International Company Information

Table 96. Boehringer Ingelheim International Description and Business Overview

Table 97. Boehringer Ingelheim International Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Boehringer Ingelheim International Oral Asthma Medications Product

Table 99. Boehringer Ingelheim International Recent Developments/Updates

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Sanofi Oral Asthma Medications Product

Table 104. Sanofi Recent Developments/Updates

Table 105. BD Company Information

Table 106. BD Description and Business Overview

Table 107. BD Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. BD Oral Asthma Medications Product

Table 109. BD Recent Developments/Updates

Table 110. Covis Pharma Company Information

Table 111. Covis Pharma Description and Business Overview

Table 112. Covis Pharma Oral Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Covis Pharma Oral Asthma Medications Product

Table 114. Covis Pharma Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Oral Asthma Medications Distributors List

Table 118. Oral Asthma Medications Customers List

Table 119. Oral Asthma Medications Market Trends

Table 120. Oral Asthma Medications Market Drivers

Table 121. Oral Asthma Medications Market Challenges

Table 122. Oral Asthma Medications Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Asthma Medications

Figure 2. Global Oral Asthma Medications Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Oral Asthma Medications Market Share by Type: 2023 & 2030

Figure 4. Tablets Product Picture

Figure 5. Capsules Product Picture

Figure 6. Global Oral Asthma Medications Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Oral Asthma Medications Market Share by Application: 2023 & 2030

Figure 8. Anti-inflammatory

Figure 9. Bronchodilators

Figure 10. Combination Therapy

Figure 11. Other

Figure 12. Global Oral Asthma Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Oral Asthma Medications Market Size (2019-2030) & (US$ Million)

Figure 14. Global Oral Asthma Medications Sales (2019-2030) & (K Units)

Figure 15. Global Oral Asthma Medications Average Price (US$/Unit) & (2019-2030)

Figure 16. Oral Asthma Medications Report Years Considered

Figure 17. Oral Asthma Medications Sales Share by Manufacturers in 2023

Figure 18. Global Oral Asthma Medications Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Oral Asthma Medications Players: Market Share by Revenue in Oral Asthma Medications in 2023

Figure 20. Oral Asthma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Oral Asthma Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Oral Asthma Medications Sales Market Share by Country (2019-2030)

Figure 23. North America Oral Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 24. United States Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Oral Asthma Medications Sales Market Share by Country (2019-2030)

Figure 27. Europe Oral Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 28. Germany Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Oral Asthma Medications Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Oral Asthma Medications Revenue Market Share by Region (2019-2030)

Figure 35. China Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Oral Asthma Medications Sales Market Share by Country (2019-2030)

Figure 43. Mexico Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Oral Asthma Medications Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Oral Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Oral Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Oral Asthma Medications by Type (2019-2030)

Figure 53. Global Revenue Market Share of Oral Asthma Medications by Type (2019-2030)

Figure 54. Global Oral Asthma Medications Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Oral Asthma Medications by Application (2019-2030)

Figure 56. Global Revenue Market Share of Oral Asthma Medications by Application (2019-2030)

Figure 57. Global Oral Asthma Medications Price (US$/Unit) by Application (2019-2030)

Figure 58. Oral Asthma Medications Value Chain

Figure 59. Oral Asthma Medications Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions